Pre-Conference Workshop Day
Tuesday, December 10, 2024
Workshop A
9.00 - 12.00
ADC Target Biology 101: A Mechanistic Deep Dive Into Your ADC Targets
As the ADC field advances, there is a growing emphasis on incorporating a stronger biological focus into ADC target selection. With an increasingly crowded landscape of ADC developers, a “first-in-class” approach to identifying novel targets that align with the intricate mechanisms of ADC design is essential. For this reason, a deep understanding of the biological interactions between ADCs and their targets remains fundamental to successful target selection.
This workshop provides a premium platform to immerse yourself in the biological discussion around ADC target selection, shifting the angle of approach to identifying the next best target.
Gather with experts to:
- Dissect the role of the ADC target through a biological lens to correlate accordingly
with ADC design - Review target properties which have a pivotal role in functionality, including
expression, stability, and localization - Align the biological and chemical strategy for ADC target selection to create a
holistic profile
Andrew Zhang
Director, Chemical
Biology
Former AstraZeneca
Lunch & Networking
12:00
Workshop B
1.00 - 4.00
Stop Chasing Shiney Bandwagons: Strategies for Discovery & Development of Innovative ADC Targets
Everyone is seeking novel targets, but where do we start?Laying out an in-depth plan of action when strategizing your ADC target selection efforts is paramount to success. A multifactorial approach is required to inform your novel target choice, seeking multiple perspectives to the decision making process. This workshop will outline the decision- making tree from concept to clinic to create a bulletproof strategy to propel your ADC target selection.
Gather with experts to:
- Explore how targets for ADC development require special considerations including
biology, copy numbers, homogeneity, and stability in expression - Discuss internalizing versus non-internalizing targets
- Learn how target discovery requires validation using appropriate linkers, payloads
and conjugation - Outline five rights to target selection, including bispecific tumor targets
- Identify the do’s and don’ts of target selection
Rakesh Dixit
CEO & President
Bioavigen Oncology
End of Pre-Conference Workshop Day
4:00